What is it about?

Although certain members of the G protein-coupled receptor family are the molecular targets for a wide range of therapeutic medicines, many members of the family are yet to be targeted in this way. The current review considers why this might be the case and uses two examples to illustrate the challenges.

Featured Image

Read the Original

This page is a summary of: G protein-coupled receptors not currently in the spotlight: free fatty acid receptor 2 and GPR35, British Journal of Pharmacology, November 2017, Wiley,
DOI: 10.1111/bph.14042.
You can read the full text:

Read

Contributors

The following have contributed to this page